This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RAD52 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RAD52 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~46.2 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 4 isoform(s) |
The M01580 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | PC3 cell lysate (catalog M01580) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M01580; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
RAD52 has a predicted monomer mass of 46.2 kDa; isoforms and heptameric rings are documented, but their effects on Western blot migration are unproven.
| Band near 46.2 kDa | Consistent with the predicted RAD52 monomer; confirm identity with a control. |
| Additional bands at different positions | Could reflect RAD52 splice isoforms; their migration is not established. |
| Higher molecular weight band | Could reflect incomplete dissociation of RAD52 heptameric rings; verify its identity. |
| Weak or absent band in a cytosolic fraction | Consistent with RAD52 nuclear localization. |
| Predicted RAD52 monomer mass | Provides a 46.2 kDa reference for the full-length protein. |
| Alpha splice isoform | Its specific mass and migration are not supplied. |
| Beta splice isoform | Its specific mass and migration are not supplied. |
| Gamma splice isoform | Its specific mass and migration are not supplied. |
| Delta splice isoform | Its specific mass and migration are not supplied. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear RAD52 may be poorly recovered during extraction. | Check nuclear extraction and compare with a nuclear-enriched sample. |
| Band higher than expected | Incomplete dissociation of RAD52 heptameric rings is possible. | Check denaturation conditions and confirm band identity with RAD52 depletion. |
| Band lower than expected | An isoform or degradation product is possible; its mass is not established. | Compare with RAD52 depletion and an antibody against another epitope. |
| Multiple bands | RAD52 has alpha, beta, gamma and delta splice isoforms, but their band positions are unknown. | Use isoform-specific controls or RAD52 depletion to identify the bands. |
| Weak or no signal | RAD52 may be under-recovered when the nuclear fraction is lost. | Check nuclear recovery with a nuclear marker and verify RAD52 antibody performance. |
| Fragments below expected size | Protein degradation during sample preparation is possible. | Prepare fresh lysate with protease inhibitors and confirm fragment identity with RAD52 depletion. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for RAD52, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
M01580 is a rabbit monoclonal anti-RAD52 antibody listed for human reactivity. Its supplied Western blot image shows RAD52 expression in PC3 cell lysate; no other sample validation is provided here.
Which to pick: M01580 is the only listed option. It has a Western blot image using PC3 cell lysate, making it the documented choice for that tested context.